All Categories
RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.
RTALB
company logo
SUMMARY FINANCIALS
(*) The information on this page is updated with a delay. The home page or search functions on the site should be used for instant data tracking.(**) The following data includes some selected items from the companys/funds financial statements. It is necessary to use the search functions on the site for complete financial statements.(***) The table below contains the data in the "current period" column of financial statements published lastly on the KAP system for the relevant year and period, and the adjustments/corrections made in the "previous period" information are not taken into account when publishing the tables for the relevant current year and period. To reach the data containing this detail, the financial report notification of the company should be used.
Statement of Financial Position (Balance Sheet)2022/122023/122024/122025/03
Presentation CurrencyTLTLTLTL
Nature of Financial StatementsConsolidatedUnconsolidatedUnconsolidatedUnconsolidated
Current Assets300.531.007249.154.843155.035.444174.924.881
Non-current Assets439.682.1761.034.798.1771.766.131.5021.939.688.289
Total Assets740.213.1831.283.953.0201.921.166.9462.114.613.170
Current Liabilities88.585.13188.819.359215.067.729166.682.434
Non-current Liabilities18.888.28675.312.27137.102.16030.421.672
Total Liabilities107.473.417164.131.630252.169.889197.104.106
Equity Attributable to Owners of Parent594.520.9961.119.821.3901.668.997.0571.917.509.064
Issued Capital100.000.000100.000.000100.000.000500.000.000
Non-controlling Interests38.218.7700
Total Equity632.739.7661.119.821.3901.668.997.0571.917.509.064
Total Liabilities and Equity740.213.1831.283.953.0201.921.166.9462.114.613.170
Statement of Profit or Loss and Other Comprehensive Income2022/122023/122024/122025/03
Presentation CurrencyTLTLTLTL
Nature of Financial StatementsConsolidatedUnconsolidatedUnconsolidatedUnconsolidated
Revenue86.025.98895.936.328158.589.92052.231.413
Cost of Sales-50.374.366-78.024.891-116.480.576-33.588.567
Gross Profit (Loss) from Commercial Operations35.651.62217.911.43742.109.34418.642.846
Revenue from Finance Sector Operations
Cost of Finance Sector Operations
Gross Profit (Loss) from Finance Sector Operations
Gross Profit (Loss)35.651.62217.911.43742.109.34418.642.846
Profit (Loss) From Operating Activities43.438.413-15.276.945-38.084.547-8.714.487
Profit (Loss) Before Financing Income (Expense)317.619.88013.814.51296.892.921202.525.205
Profit (Loss) from Continuing Operations, Before Tax302.476.928-72.561.158-51.662.864234.883.872
Profit (Loss) from Continuing Operations287.938.191-71.452.01152.234.738214.971.181
Profit (Loss) from Discontinued Operations
Net Profit (Loss)287.938.191-71.452.01152.234.738214.971.181
Profit (Loss) Attributable To, Non-controlling Interests6.821.185000
Profit (Loss) Attributable To, Owners of Parent281.117.006-71.452.01152.234.738214.971.181
Other Comprehensive Income (Loss) -327.679814.660-22.049-159.566
Total Comprehensive Income (Loss) 287.610.512-70.637.35152.212.689214.811.615
Total Comprehensive Income Attributable To, Non-controlling Interests6.821.185000
Total Comprehensive Income Attributable To, Owners of Parent280.789.327-70.637.35152.212.689214.811.615